HSBC Holdings
SMMT icon

HSBC Holdings’s Summit Therapeutics SMMT Stock Holding History

HSBC Holdings’s Portfolio SMMT Stock Details SMMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.78M Buy
+120,560
New +$2.14M ﹤0.01% 1640
2026
Q1 		– Sell
-98,766
Closed -$1.72M – 3201
2025
Q4 		$1.72M Buy
+98,766
New +$1.86M ﹤0.01% 1639
2025
Q2 		– Sell
-10,672
Closed -$204K – 3222
2025
Q1 		$204K Sell
10,672
-28
-0.3% -$562 ﹤0.01% 2608
2024
Q4 		$188K Buy
+10,700
New +$207K ﹤0.01% 2736
2020
Q4 		– Sell
-27,342
Closed -$94K – 3134
2020
Q3 		$94K Sell
27,342
-123,633
-82% -$428K ﹤0.01% 2629
2020
Q2 		$448K Sell
150,975
-40,508
-21% -$140K ﹤0.01% 1908
2020
Q1 		$458K Buy
+191,483
New +$329K ﹤0.01% 1824

Other funds holding SMMT

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

HSBC Holdings's SMMT Position: Q2 2026 in Review

HSBC Holdings opened a new position in Summit Therapeutics (SMMT) in Q2 2026: 120,560 shares worth $1.78M. The stake represents ﹤0.01% of the portfolio and ranks #1640 among its holdings. This is a return to the name: HSBC Holdings previously reported a position in SMMT as recently as Q4 2025.

HSBC Holdings first reported a position in SMMT in Q1 2020 and has held it in 7 quarters since. 243 funds tracked by Wall St. Rank hold SMMT as of Q2 2026.

  • HSBC Holdings held 120,560 shares of Summit Therapeutics worth $1.78M as of Q2 2026.
  • Summit Therapeutics was a new HSBC Holdings position in Q2 2026.
  • Summit Therapeutics made up ﹤0.01% of HSBC Holdings's portfolio in Q2 2026, its #1640 holding.
  • HSBC Holdings first reported a position in Summit Therapeutics in Q1 2020 and has held it in 7 quarters since.
  • 243 funds tracked by Wall St. Rank held Summit Therapeutics as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.